India to Sri Lanka: Imipenem Export Trade Route

The India to Sri Lanka Imipenem corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $2.5M USD. The route is dominated by SWISS PARENTERALS LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's imipenem manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $274.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with imipenem's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.8%, placing it at rank #11 among India's top imipenem export destinations globally.

On the import side, key buyers of Indian imipenem in Sri Lanka include BANK OF CEYLON, TO THE ORDER , P T C MEDICAL PRIVATE LIMITED and 3 others. BANK OF CEYLON is the single largest importer with 2 shipments valued at $1.2M USD.

India's imipenem exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. SWISS PARENTERALS LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SWISS PARENTERALS LIMITED, MAAN PHARMACEUTICALS LIMITED, UNITED BIOTECH PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $274.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical goods/harmless medicinesfor human use - imipenem & cilastatin for inj. usp 500 mg 140000 vials and pharmaceutical goods/harmless medicinesfor human use - imipenem & cilastatin for inj. usp 500 mg 100000 vials, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BANK OF CEYLON is the largest importer with 2 shipments worth $1.2M USD — representing 47% of all imipenem imports from India on this route. A total of 6 buyers are active on this corridor.